Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.60
-1.36 (-0.66%)
AAPL  276.27
+2.59 (0.95%)
AMD  218.88
+5.31 (2.49%)
BAC  55.37
-0.02 (-0.04%)
GOOG  317.70
-0.93 (-0.29%)
META  669.61
-1.11 (-0.16%)
MSFT  408.96
-4.31 (-1.04%)
NVDA  192.43
+3.89 (2.06%)
ORCL  160.74
+0.85 (0.53%)
TSLA  435.15
+9.94 (2.34%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.